Description
SPRINGER Vaccine Design Methods And Protocols Volume 1 Vaccines For Human Diseases 2Ed (Hb 2022) by THOMAS S.
This volume provides a practical guide providing step-by-step protocol to design and develop vaccines for human diseases. Divided into three volumes, Volume 1: Vaccines for Human Diseases guides readers through an introductory section on future challenges for vaccinologists and the immunological mechanism of vaccines. Chapters focus on design of human vaccines for viral, bacterial, fungal, and parasitic diseases as well as tumor vaccines. Written in the format of the highly successful Methods in Molecular Biology series, each chapter includes an introduction to the topic, lists necessary materials and reagents, includes tips on troubleshooting and known pitfalls, and step-by-step, readily reproducible protocols.Authoritative and practical, Vaccine Design: Methods and Protocols, Second Edition, Volume 1: Vaccines for Human Diseases aims to be a useful practical guide to researchers to help further their study in this field. PART I VACCINES: INTRODUCTION1. Challenges for Vaccinologists in the First Half of the Twenty First CenturySunil Thomas, Ann Abraham, Patrick J. Callaghan, and Rino Rappuoli2. Principles in Immunology for the Design and Development of VaccinesClaudius U. Meyer and Fred Zepp3. Revisiting the Principles of Designing a Vaccine Shubhranshu Zutshi, Sunil Kumar, Prashant Chauhan, Bhaskar Saha4. Status of COVID-19 Pandemic before the Administration of VaccineSunil ThomasPART II TRENDS IN VACCINOLOGY5. mRNA Vaccines to Protect against DiseasesSunil Thomas and Ann Abraham 6. Artificial Intelligence in Vaccine and Drug DesignSunil Thomas, Ann Abraham, Jeremy Baldwin, Sakshi Piplani, and Nikolai PetrovskyPART III VACCINES FOR HUMAN VIRAL DISEASES7. Vaccines Targeting Numerous Coronavirus Antigens, Ensuring Broader Global Population Coverage: Multi-Epitope and Multi-Patch VaccinesSukrit Srivastava, Spyros D. Chatziefthymiou, Michael Kolbe8. Use of Micro-computed Tomography to Visualize and Quantify COVID-19 Vaccine Efficiency in Free-breathing HamstersLaura Seldeslachts, Christopher Cawthorne, Suzanne F. Kaptein, Robbert Boudewijns, Hendrik Jan Thibaut, Lorena Sanchez Felipe, Sapna Sharma, Georg Schramm, Birgit Weynand, Kai Dallmeier and Greetje Vande Velde9. Design of Replication-Competent VSV- and Ervebo-vectored Vaccines against SARS-CoV-2Qixing Liu, Zhe Ding, Jiaming Lan, and Gary Wong10. CRISPR Engineering of Bacteriophage T4 to Design Vaccines against SARS-CoV-2 and Emerging PathogensJingen Zhu, Neeti Ananthaswamy, Swati Jain, Himanshu Batra, Wei-Chun Tang, and Venigalla B. Rao11. Techniques for Developing and Assessing Immune Responses Induced by Synthetic DNA Vaccines for Emerging Infectious DiseasesZiyang Xu, Michelle Ho, Devivasha Bordoloi, Sagar Kudchodkar, Makan Khoshnejad, Leila Giron, Faraz Zaidi, Moonsup Jeong, Christine C. Roberts, Young K. Park, Joel Maslow, Mohamed Abdel-Mohsen, and Kar Muthumani12. Towards Determining the Epitopes of the Structural proteins of SARS-CoV-2Sunil Thomas 13. Development, production and characterization of hepatitis B subviral envelope particles as a third-generation vaccineJuan Manuel Battagliotti, Diego Fontana, Marina Etcheverrigaray, Ricardo Kratje, and Claudio Prieto14. Generation of CpG-Recoded Zika Virus Vaccine Candidates Ivan Trus, Daniel Udenze, Uladzimir KarniychukPART IV VACCINES FOR HUMAN BACTERIAL DISEASES15. Salmonella Uptake into Gut-Associated Lymphoid Tissues: Implications for Targeted Mucosal Vaccine Design and DeliveryAngelene F. Richards, Fernando J. Torres-Velez, and Nicholas J. Mantis16. Development of Human Recombinant Leptospirosis VaccinesNatasha Rodrigues de Oliveira, Thais Larre Oliveira, Sergio Jorge, and Odir Antonio Dellagostin17. Induction of T-cell Responses by Vaccination of a Streptococcus pneumoniae Whole Cell VaccineEmily M. Roy, Fan Zhang, Richard Malley, and Ying-Jie Lu18. Development of a Bacterial Nanoparticle Vaccine against Escherichia coliMelibea Berzosa, Yadira Pastor, Carlos Gamazo, and Juan Manuel Irache19. Construction of Novel Live Genetically Modified BCG Vaccine Candidates using Recombineering ToolsMario Alberto Flores-Valdez and Michel de Jesus Aceves-Sanchez20. An Update on Tuberculosis VaccinesRadha Gopalaswamy and Selvakumar Subbian21. Structure-Based Design of Diagnostics and Vaccines for Lyme DiseaseSunil Thomas22. Development of a SONIX vaccine to protect against ehrlichiosisSunil Thomas PART V VACCINES FOR HUMAN PARASITIC DISEASES23. Development of the Anti-Leishmanial VaccineSunil Kumar, Shubhranshu Zutshi, Mukesh Kumar Jha, Prashant Chauhan, and Bhaskar Saha 24. In Silico Design of Recombinant Chimera T Cell Peptide Epitope Vaccines for Visceral LeishmaniasisAmanda Sanchez Machado, Vivian Tamietti Martins, Maria Victoria Humbert, Myron Christodoulides, and Eduardo Antonio Ferraz Coelho25. Pre-clinical Assessment of the Immunogenicity of Experimental Leishmania VaccinesVivian Tamietti Martins, Amanda Sanchez Machado, Maria Victoria Humbert, Myron Christodoulides, Eduardo Antonio Ferraz Coelho26. Production of Oral Vaccines Based on Retrovirus Virus-like Particles Pseudotyped with Protozoan-Surface ProteinsLucia Lara Rupil, Marianela del Carmen Serradell, and Hugo Daniel Lujan27. A Fast-Track Phenotypic Characterization of Plasmodium falciparum Vaccine Antigens through Lyse-Reseal Erythrocytes Mediated Delivery (LyRED) of RNA Interference for Targeted Translational RepressionMalabika Chakrabarti, Swati Garg, Akshay Munjal, Sweta Karan, Soumya Pati, Lalit C. Garg, and Shailja Singh28. Plasmodium falciparum Antigen Expression in Leishmania Parasite: A Way Forward for Live Attenuated Vaccine DevelopmentAkriti Srivastava, Swati Garg, Sweta Karan, Shikha Kaushik, Anand Ranganathan, Soumya Pati, Lalit C. Garg and Shailja Singh29. Molecular Characterization of a Vector-based Candidate Antigen using the 3'-RACE and Genome Walking Methods and In Silico Analysis of the Correspondent Protein for Vaccine Design and DevelopmentAbbasali Raz, Mahdieh Manafi, and Mahdokht Ilbeig Khamseh Nejad30. In vitro culture of Plasmodium falciparum for the Production of Mature Gametocytes for Performing Standard Membrane Feeding Assay and Infection of Anopheles spp.Abbasali Raz and Mahdokht Ilbeigi Khamseh Nejad31. Plasmodium berghei Infection in BALB/c Mice Model as an Animal Model for Malaria Disease ResearchAbbasali Raz32. Standard membrane feeding assay for malaria transmission studies Abbasali Raz, Jafar J. Sani, and Hemn YousefiPART VI DEVELOPMENT OF CANCER VACCINES33. Generation of Tumor Targeted Dendritic Cell Vaccines with Improved Immunogenic and Migratory PhenotypeAdam M. Swartz, Kelly M. Hotchkiss, Smita K. Nair, John H. Sampson, and Kristen A. Batich34. Monocytes as a Cellular Vaccine Platform to Induce Anti-Tumor ImmunityMin-Nung Huang, Vincent M. D'Anniballe, and Michael D. Gunn35. Beyond Sequencing: Prioritizing and Delivering Neoantigens for Cancer VaccinesAlexander S. Roesler and Karen S. AndersonPART VII VACCINES FOR ALLERGY36. Proteomics for Development of Food Allergy VaccinesMonica Carrera and Susana MagadanPART VIII VACCINES FOR TOXINS37. Estimating Vaccine Potency using Antibody-based Competition AssaysJennifer Doering, Greta Van Slyke, Oreola Donini, and Nicholas J Mantis